1. Home
  2. BTSG vs LMAT Comparison

BTSG vs LMAT Comparison

Compare BTSG & LMAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BTSG
  • LMAT
  • Stock Information
  • Founded
  • BTSG 1974
  • LMAT 1983
  • Country
  • BTSG United States
  • LMAT United States
  • Employees
  • BTSG N/A
  • LMAT N/A
  • Industry
  • BTSG
  • LMAT Medical/Dental Instruments
  • Sector
  • BTSG
  • LMAT Health Care
  • Exchange
  • BTSG NYSE
  • LMAT Nasdaq
  • Market Cap
  • BTSG 2.0B
  • LMAT 2.0B
  • IPO Year
  • BTSG 2024
  • LMAT 2006
  • Fundamental
  • Price
  • BTSG $18.75
  • LMAT $105.87
  • Analyst Decision
  • BTSG Strong Buy
  • LMAT Buy
  • Analyst Count
  • BTSG 12
  • LMAT 7
  • Target Price
  • BTSG $16.86
  • LMAT $92.83
  • AVG Volume (30 Days)
  • BTSG 1.5M
  • LMAT 139.9K
  • Earning Date
  • BTSG 11-01-2024
  • LMAT 10-31-2024
  • Dividend Yield
  • BTSG N/A
  • LMAT 0.60%
  • EPS Growth
  • BTSG N/A
  • LMAT 49.21
  • EPS
  • BTSG N/A
  • LMAT 1.82
  • Revenue
  • BTSG $10,588,215,000.00
  • LMAT $213,029,000.00
  • Revenue This Year
  • BTSG $28.69
  • LMAT $16.04
  • Revenue Next Year
  • BTSG $10.47
  • LMAT $9.62
  • P/E Ratio
  • BTSG N/A
  • LMAT $58.04
  • Revenue Growth
  • BTSG 25.72
  • LMAT 14.81
  • 52 Week Low
  • BTSG $7.85
  • LMAT $51.70
  • 52 Week High
  • BTSG $20.25
  • LMAT $106.99
  • Technical
  • Relative Strength Index (RSI)
  • BTSG 60.55
  • LMAT 70.41
  • Support Level
  • BTSG $18.27
  • LMAT $100.45
  • Resistance Level
  • BTSG $19.90
  • LMAT $104.82
  • Average True Range (ATR)
  • BTSG 0.76
  • LMAT 2.95
  • MACD
  • BTSG -0.08
  • LMAT 0.34
  • Stochastic Oscillator
  • BTSG 59.91
  • LMAT 91.24

About BTSG BRIGHTSPRING HEALTH SERVICES INC

BrightSpring Health Services Inc is a home and community-based healthcare services platform, focused on delivering complementary pharmacy and provider services to complex patients. Its platform delivers clinical services and pharmacy solutions across Medicare, Medicaid, and commercially insured populations. Its segments include Pharmacy Solutions, Provider Service. and others. It generates the majority of its revenue from the Pharmacy Solutions segment.

About LMAT LeMaitre Vascular Inc.

LeMaitre Vascular Inc manufactures and distributes medical devices for the treatment of peripheral vascular disease. Its products are used during open vascular surgery and address several anatomical areas, such as the carotid, lower extremities, upper extremities, and aorta. The firm's lower extremities product line contributes towards the proportion of revenue, followed by the carotid product line. LeMaitre's surgical devices include angioscopes, balloon catheters, carotid shunts, phlebectomy devices, vascular grafts, vascular patches, and vessel closure systems. LeMaitre generates the majority of its revenue in the United States.

Share on Social Networks: